MedPath

Use of Continence Care Protocol in UK Nursing Homes.

Completed
Conditions
Urinary Incontinence
Urinary Incontinence Due to Cognitive Impairment
Interventions
Other: Skin and leakage protocol
Registration Number
NCT06100458
Lead Sponsor
Essity Hygiene and Health AB
Brief Summary

This is a retrospective cohort study. In the investigation the clinical use of the Skin and leakage protocol (SLEP) is to be investigated. The SLEP is a generic digital diary form filled out to give information about the current status of continence care among care home residents. The SLEP tracks the number of leakage occurrences and daily skin health over a period of time with the purpose of assisting care staff in making decisions regarding continence care. The SLEP has been introduced at several United kingdom National Health Service care homes and with this investigation the investigators want to retrospectively analyse the data to determine the clinical usefulness of the form.

The primary objective of the study is to describe any changes in product leakage rate at the baseline and follow up time period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
49
Inclusion Criteria
  • Subject is diagnosed with urinary incontinence managed with an absorbing incontinence product.
  • The skin and leakage protocol have been used in the care of the subject and there is data from at least two measurements.
  • Subject is cared for in a Residential care home using the skin and leakage protocol.
  • Subject is over 18 years of age.
Exclusion Criteria
  • Subject is not using an absorbing incontinence product to manage incontinence.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Protocol armSkin and leakage protocolThe skin and leakage protocol was used over a 5 day baseline period. The follow up was done 25 days later by another 5 day period of protocol use to observe any changes in continence care.
Primary Outcome Measures
NameTimeMethod
Change in leakage rate28 days

Change in absorbing product leakage rate between baseline and follow up period

Secondary Outcome Measures
NameTimeMethod
Change in skin health score28 days

Change in skin health assessment score between the baseline and follow up period. The skin assessment is conducted on a scale from 1-5 were 1 represents no presence of skin irritation and 5 represents severe skin problems.

Subject care profile28 days

The care needs profiles of the subjects using the skin and leakage protocol. According to specific criteria for degree of confusion and mobility subjects can be assigned one of 6 different profiles. The profiles are arranged on a scale from 1-6 were 1 is lowest level of care need and 6 is the highest.

Trial Locations

Locations (1)

Lincolnshire Community Health Services NHS Trust

🇬🇧

Lincoln, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath